The History Of Medications For Women

The first work of its kind, The History of Medications for Women: Materia medica woman is a richly detailed, far-ranging illustrated history of medications for women in all the great cultures and civilizations, from ancient times to the present. Compiled by an acclaimed author of medical history literature, this is the only book that extends from the earliest uses of ergometrine, lettuce, and mummy medicine, through the history of women's medications in ancient Assyria and Egypt, and into the 16th through 20th centuries. With the main sections organized by origin and timeline, the book contains lists of medications used by women from earliest times to the present accompanied by historically-based text. The author includes botanical, chemical, pharmacalogical, and therapeutic details where appropriate, as well as extensive quotations from both contemporary and old, rare books. The text is complemented with the history of obstetrics and gynecology, along with short biographies and illustrations. Additionally, the author presents a unique fund of hard-to-find information in sections devoted to topics such as anesthesia and analgesia, antiseptics, antibiotics and chemotherapy, blood transfusion and Rhesus disease, eclampsia, family planning, menopause, and uterine stimulants. Interesting and thought-provoking, The History of Medications for Women will not only provide an enjoyable read, but will allow you to appreciate the past and look at the future with a new perspective.

Drugs are considered to be healers and harmers, wonder substances and knowledge makers; objects that impact on social hierarchies, health practices and public policies. As a collective endeavour, this book focuses on the ways that gender, along with race/ethnicity and class, influence the design, standardisation and circulation of drugs throughout several highly medicalised countries throughout the twentieth century and until the twenty-first. Fourteen authors from different European and non-European countries analyse the extent to which the dominant ideas and values surrounding masculinity and femininity have contributed to shape the research, prescription and use of drugs by women and men within particular social and cultural contexts. New and lesser-known, gender-specific issues in lifestyles and social practices associated with pharmaceutical technologies are analysed, as is the manner in which they intervene in life experiences such as reproduction, sexual desire, childbirth, depression and happiness. The processes of prescribing, selling, marketing and accepting or forbidding drugs is also examined, as is the contribution of gendered medical practices to the medicalisation and growing consumption of drugs by women. Gender relations and other hierarchies are involved as both causes and consequences of drug cultures, and of the history and social life of gender in contemporary drug production, use and consumption. A network of agents emerges from this book’s research, contributing to a better understanding of both gender and drugs within our society.

A trailblazing, conversation-starting history of women’s health—from the earliest medical ideas about women’s illnesses to hormones and autoimmune diseases—brought together in a fascinating sweeping narrative. Elinor Cleghorn became an unwell woman ten years ago. She was diagnosed with an autoimmune disease after a long period of being told her symptoms were anything from psychosomatic to a possible pregnancy. As Elinor learned to live with her unpredictable disease she turned to history for answers, and found an enraging legacy of suffering, mystification, and misdiagnosis. In Unwell Women, Elinor Cleghorn traces the almost unbelievable history of how medicine has failed women by treating their bodies as alien and other, often to perilous effect. The result is an authoritative and groundbreaking exploration of the relationship between women and medical practice, from the "wandering womb" of Ancient Greece to the rise of witch trials across Europe, and from the dawn of hysteria as a catchall for difficult-to-diagnose disorders to the first forays into autoimmunity and the shifting understanding of hormones, menstruation, menopause, and conditions like endometriosis. Packed with character studies and case histories of women who have suffered, challenged, and rewritten medical orthodoxy—and the men who controlled their fate—this is a revolutionary examination of the relationship between women, illness, and medicine. With these case histories, Elinor pays homage to the women who suffered so strides could be made, and shows how being unwell has become normalized in society and culture, where women have long been distrusted as reliable narrators of their own bodies and pain. But the time for real change is long overdue: answers reside in the body, in the testimonies of unwell women—and their lives depend on medicine learning to listen.

Excerpt from A History of Women in Medicine: From the Earliest Times to the Beginning of the Nineteenth Century And we are faced with more than documentary mistakes. With iwoi'nen far more than with men tradition has been prone to garble and distort the original data. But this very fact increases the reliability of those stories of the work of medical women which have persisted down the ages, surviving jealousy, calumny, carelessness and indifference. If _any traditions of medical women survived all these handicaps, it is all the more probable that they were based on solid and substantial fact. About the Publisher Forgotten Books publishes hundreds of thousands of rare and classic books. Find more at www.forgottenbooks.com This book is a reproduction of an important historical work. Forgotten Books uses state-of-the-art technology to digitally reconstruct the work, preserving the original format whilst repairing imperfections present in the aged copy. In rare cases, an imperfection in the original, such as a blemish or missing page, may be replicated in our edition. We do, however, repair the vast majority of imperfections successfully; any imperfections that remain are intentionally left to preserve the state of such historical works.

Among the many who serve in the United States Armed Forces and who are deployed to distant locations around the world, myriad health threats are encountered. In addition to those associated with the disruption of their home life and potential for combat, they may face distinctive disease threats that are specific to the locations to which they are deployed. U.S. forces have been deployed many times over the years to areas in which malaria is endemic, including in parts of Afghanistan and Iraq. Department of Defense (DoD) policy requires that antimalarial drugs be issued and regimens adhered to for deployments to malaria-endemic areas. Policies directing which should be used as first and as second-line agents have evolved over time based on new data regarding adverse events or precautions for specific underlying health conditions, areas of deployment, and other operational factors At the request of the Veterans Administration, Assessment of Long-Term Health Effects of Antimalarial Drugs When Used for Prophylaxis assesses the scientific evidence regarding the potential for long-term health effects resulting from the use of antimalarial drugs that were approved by FDA or used by U.S. service members for malaria prophylaxis, with a focus on mefloquine, tafenoquine, and other antimalarial drugs that have been used by DoD in the past 25 years. This report offers conclusions based on available evidence regarding associations of persistent or latent adverse events.